Navigation Links
ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
Date:3/29/2011

mercially known as Cinryze® (C1 Esterase Inhibitor [Human]), is indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease.

About Antibody Mediated Rejection

Antibody-mediated rejection is a type of organ transplant rejection that occurs when a patient has antibodies circulating in their blood against the donor organ (i.e. donor specific antibodies, or DSA).  These antibodies can activate the body's own defense mechanism, known as the complement cascade, which in turn causes a complement-mediated destruction of the transplanted organ.  Since there is no approved treatment for AMR, many thousands of renal failure patients that have DSA cannot be transplanted.  Furthermore, over time, all transplant patients can develop DSA and could lose their transplant to a chronic version of antibody/complement-mediated rejection of the transplanted organ.

About Cinryze® (C1 esterase inhibitor [human])

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor product that has been approved by the U.S. FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE.  C1 inhibitor therapy has been used acutely for more than 35 years in Europe to treat patients with C1 inhibitor deficiency. In the E.U., on March 17, 2011., the CHMP adopted a positive opinion for Cinryze for treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE), and routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments or patients who are inadequately managed with repeated acute treatment. The CHMP positive opinion forms the
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
2. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
3. ViroPharma Announces Securities Repurchase Program
4. ViroPharma to Participate in Two March Healthcare Conferences
5. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
6. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
7. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
8. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
9. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
10. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
11. ViroPharma To Participate in Two September Healthcare Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal, and metabolic diseases, today ... evaluating tenapanor in Stage 3 chronic kidney disease ... did not meet the primary endpoint of decreasing ... to patients receiving placebo. Ardelyx ...
(Date:5/5/2015)... 2015 (Family Features) Which health screenings and ... most adults, monitoring your weight, cholesterol, and blood pressure ... what about vision care? Photo - ... their 40s, they often start to notice small changes ... and job performance. Whether having difficulty reading a book ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Electro Surgical Market" report ... market is expected to achieve a CAGR of ... offer huge benefits for patients as well as ... infections, condensed visible marks, bleeding control and improved ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Global Electro Surgical Market 2015 2
... 7, 2012 H. D. Smith, among the nation,s ... agreement with PharmacyGPO, a buying group that services independent ... Under the terms of the agreement, H. D. Smith ... of products including pharmaceuticals, health and wellness products and ...
... May 7, 2012  Biodel Inc. (Nasdaq: BIOD ) ... on May 10, 2012.  Following the release of the company,s ... to discuss the results and provide an update on the ... year 2012 results will be distributed8:15 am EDT: , Conference ...
Cached Medicine Technology:H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group 2H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group 3
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the ... research, outreach and patient advocacy programs. The gala evening included ... attracted hundreds of supporters. , The 2015 gala was dedicated ... B virus (HBV) by Dr. Baruch S. Blumberg, who passed ... Medicine for his discovery of the virus in 1976. He ...
(Date:5/5/2015)... Chicago, IL (PRWEB) May 05, 2015 ... AvePoint, the established leader in enabling ... new tools to help customers speed up and ... Microsoft Azure technologies, AvePoint Solutions for Office ... Office 365 faster while ensuring sustainable user adoption ...
(Date:5/5/2015)... The newly minted Regan Arts has just released a ... Reedy from his 20 years working in the field of ... to publish a parenting book and why this one, she replied, ... idea that it is a journey, not a destination...that the question ... trek sometimes together and sometimes not...that each of our struggles is ...
(Date:5/5/2015)... 2015 Sunny skies and cool temperatures made ... nearly 400 runners and walkers participated in Global Lyme Alliance’s ... $35,000. , The 5K and 10K runs and 1-and ... and to raise funds for tick-borne disease research. The “Lyme ... the recent merger of Lyme Research Alliance (LRA) and ...
(Date:5/5/2015)... 05, 2015 Nutritional science and medical ... a variety of health conditions and illnesses linked to ... to adopt clean eating methods to rid the body ... with over-consumption of fast and processed foods. Patients find ... to follow and report feeling better and losing excess ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3
... 29 Ingenious Med, the leader in inpatient,practice ... the,company approaches exciting new milestones. Record sales and ... Ingenious Med even closer to,the 4,000 user mark, ... of,2008. In addition, the company expects to reach ...
... majority of general internists and pediatricians in the United ... for young adults with complex chronic illnesses that originate ... survey. , The survey, conducted by researchers at the ... Michigan, examined a random sample of internists and pediatricians ...
... reliable results , , TUESDAY, July 29 (HealthDay News) -- ... care and research, but most tests aren,t administered according ... Center researchers. , In cancer care, exercise tests are ... patients. In cancer research, exercise tests are most often ...
... 40 years of ... brand marketing expertise, CHICAGO, July 29 The Cambridge Group, ... firm as a director., Mr. Marineau brings 40 years of ... to the firm. He,recently retired as president and CEO of Levi ...
... YORK, July 29 Care Investment Trust Inc.,(NYSE: ... quarter 2008,financial results before the market opens on Tuesday, ... conference call on Tuesday, August 12, 2008, at,11:00 a.m. ... call may,be accessed live by dialing 800-240-7305 or by ...
... may leave a mark on the brain, by changing ... and problems with attention. For one in six Americans ... often trigger more frequent urges to urinate, such mind-body ... , "We often tend to focus on just one ...
Cached Medicine News:Health News:Ingenious Med Continues Record Customer Growth and Approaches Key Milestones 2Health News:Ingenious Med Continues Record Customer Growth and Approaches Key Milestones 3Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 2Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 3Health News:Exercise Testing for Cancer Fails to Follow Guidelines 2Health News:The Cambridge Group Names Philip Marineau a Director 2Health News:Findings on bladder-brain link may point to better treatments for problems in sleep, attention 2
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
Mx3000P instrument, notebook computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, H...
... detection system offers an affordable alternative for ... such as FAM and SYBR Green I. ... thermal cycler, offering superior features such as ... MyiQ real-time PCR detection system is a ...
... The SmartCycler System is a rapid, ... from prepared biological samples. By automating much ... reaction site individually programmable, it is the ... system now on the market. The SmartCycler ...
Medicine Products: